Ana Quinn

Ana Quinn is Senior Manager at Pharmalex.

  • AdobeStock_168373953

    Navigating the MDR’s heightened surveillance and performance requirements


    Substantial changes to post-market surveillance, post-market clinical follow-up and the new requirement to include a summary of safety and clinical performance, have all placed greater obligations on medical device manufacturers. The changes introduced by the Medical Device Regulation (MDR), have the overarching objective of improving patient safety and providing greater ...